Jiewen Peng
- Topics
- Hepatitis B Virus Studies (3 papers)Cancer Treatment and Pharmacology (3 papers)Breast Lesions and Carcinomas (2 papers)
- Cited by
- HepatologyOncologyCancer Research
- Partner nations
- China
In The Last Decade
Jiewen Peng
9 papers receiving 465 citations
Peers
Comparison fields: 5 of 52
- Oncology 242
- Hepatology 171
- Epidemiology 168
- Cancer Research 130
- Pulmonary and Respiratory Medicine 90
Countries citing papers authored by Jiewen Peng
This map shows the geographic impact of Jiewen Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiewen Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiewen Peng more than expected).
Fields of papers citing papers by Jiewen Peng
This network shows the impact of papers produced by Jiewen Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiewen Peng. The network helps show where Jiewen Peng may publish in the future.
Co-authorship network of co-authors of Jiewen Peng
This figure shows the co-authorship network connecting the top 25 collaborators of Jiewen Peng. A scholar is included among the top collaborators of Jiewen Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiewen Peng. Jiewen Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 14 | |
| 4 | 17 | |
| 5 | 24 | |
| 6 | 62 | |
| 7 | 0 | |
| 8 | Entecavir vs Lamivudine for Prevention of Hepatitis B Virus Reactivation Among Patients With Untreated Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy | 4 |
| 9 | 166 | |
| 10 | 34 | |
| 11 | 137 | |
| 12 | 13 |
About Jiewen Peng
Jiewen Peng is a scholar working on Hepatology, Oncology and Otorhinolaryngology, having authored 12 papers that have together received 471 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (3 papers), Cancer Treatment and Pharmacology (3 papers) and Breast Lesions and Carcinomas (2 papers). The work is most often cited by research in Hepatology (171 citations), Oncology (242 citations) and Cancer Research (130 citations). Jiewen Peng has collaborated with scholars based in China. Frequent co-authors include Gui‐Nan Lin, Roujun Peng, Xiaomei Jiang, Zhongyu Yuan, Tao Qin, Shusen Wang, Jiehua He, Yingcheng Lin, He Huang and Sheng Ye. Their work appears in journals such as JAMA, Journal of Clinical Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.